Aster DM Healthcare Ltd
Aster DM Healthcare Ltd (ASTERDM) last traded at ₹764, a market capitalisation of ₹66,626 crore, on a P/E of 185. Over the past 52 weeks the stock has ranged between ₹519 and ₹891. Aster DM Healthcare Ltd last reported results for the quarter ended Jun 2026, with sales of ₹1,311 crore and net profit of ₹29 crore. The next scheduled event is a merger acquisition on 28 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Aster DM Healthcare Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Aster DM Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹1,311 cr, up 21.6% from ₹1,078 cr a year earlier. Net profit was ₹29 cr, down 69.1% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,086 | 1,050 | 1,000 | 1,078 | 1,197 | 1,186 | 1,182 | 1,311 |
| Expenses | 869 | 864 | 818 | 876 | 961 | 983 | 958 | 1,055 |
| Operating profit | 217 | 186 | 182 | 202 | 236 | 202 | 224 | 256 |
| OPM % | 20% | 18% | 18% | 19% | 20% | 17% | 19% | 20% |
| Other income | 35 | 9 | 5 | 29 | 28 | -0 | 37 | -77 |
| Interest | 31 | 31 | 32 | 31 | 31 | 31 | 30 | 31 |
| Depreciation | 62 | 62 | 64 | 63 | 66 | 68 | 67 | 69 |
| Profit before tax | 159 | 102 | 91 | 136 | 167 | 103 | 163 | 78 |
| Tax % | 33% | 37% | 6% | 31% | 27% | 43% | 6% | 62% |
| Net profit | 106 | 64 | 86 | 94 | 121 | 59 | 154 | 29 |
| EPS (₹) | 1.94 | 1.14 | 1.58 | 1.65 | 2.12 | 1.01 | 2.71 | 0.31 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Aster DM Healthcare Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 8,608 | 10,253 | 2,994 | 3,699 | 4,138 | 4,643 | 4,876 |
| Operating profit | 1,103 | 1,533 | 447 | 575 | 754 | 864 | 918 |
| OPM % | 13% | 15% | 15% | 16% | 18% | 19% | 19% |
| Net profit | 178 | 601 | 475 | 212 | 5,408 | 427 | 363 |
| EPS (₹) | 2.96 | 10.53 | 8.51 | 2.59 | 107.66 | 7.49 | 6.15 |
TTM is the trailing twelve months to the most recent quarter.
Aster DM Healthcare Ltd growth and returns
- 10 Years
- -1%
- 5 Years
- -12%
- 3 Years
- 16%
- TTM
- 16%
- 10 Years
- 48%
- 5 Years
- 23%
- 3 Years
- -1%
- TTM
- 2%
- 10 Years
- %
- 5 Years
- 31%
- 3 Years
- 33%
- 1 Year
- 25%
- 10 Years
- 8%
- 5 Years
- 9%
- 3 Years
- 7%
- Last Year
- 11%
Aster DM Healthcare Ltd shareholding pattern
Promoters held 53.72% at Jul 2026, up from 40.39% at Sep 2025. FIIs 10.32% and DIIs 16.48%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 41.88% | 41.89% | 40.39% | 40.39% | 40.39% | 40.39% | 40.39% | 53.72% |
| FIIs | 22.62% | 21.66% | 19.64% | 18.72% | 18.46% | 17.18% | 10.53% | 10.32% |
| DIIs | 22.91% | 24.58% | 25.28% | 26.32% | 26.12% | 27.57% | 27.65% | 16.48% |
| Public | 12.30% | 11.60% | 14.45% | 14.33% | 14.80% | 14.61% | 21.41% | 19.48% |
| No. of shareholders | 1,59,038 | 1,54,014 | 1,48,139 | 1,47,304 | 1,46,998 | 1,36,892 | 1,33,444 | 1,33,338 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Aster DM Healthcare Ltd events
The next scheduled event is a merger acquisition on 28 Sept 2026.
- Merger acquisitionAcquisition of additional 12% stake in subsidiary United CIIGMA Institute of Medical Sciences and AGM notice
See the full results calendar for every Indian company reporting in the next 30 days.
Aster DM Healthcare Ltd corporate filings
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GLAS Trust (Singapore) LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Aster DM Quality Care Ltd has reported a significant reduction in pledged shares, with…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Deutsche Bank AGInsider Trading / SASTmedium impact
Cruxal's analysis: Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited) has disclosed that…
Read the full analysis - The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on August ....Insider Trading / SASTlow impact
Cruxal's analysis: The exchange received a disclosure regarding the encumbrance of shares by promoter entity…
Read the full analysis - The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 21, 2026 for BCP Asia II Topco IV Pte LtdInsider Trading / SASThigh impact
Cruxal's analysis: Aster DM Quality Care Limited promoter, BCP Asia II Topco IV Pte. Ltd., has created an…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for GLAS Trust (Singapore) LtdInsider Trading / SASTlow impact
Cruxal's analysis: Aster DM Quality Care Ltd has reported that GLAS Trust (Singapore) Ltd, acting as an…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Centella Mauritius Holdings LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Aster DM Quality Care Limited has witnessed a significant stake sale by a major…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Centella Mauritius Holdings LtdInsider Trading / SASTmedium impact
Cruxal's analysis: Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited) has completed the…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship LtdInsider Trading / SASThigh impact
Cruxal's analysis: Aster DM Quality Care Limited has witnessed a significant reduction in promoter/investor…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship LtdInsider Trading / SASTlow impact
Cruxal's analysis: Aster DM Quality Care Ltd has seen an increase in pledged shares held by Catalyst…
Read the full analysis - Intimation regarding receipt of trading approval for equity shares allotted in terms of Scheme of AmalgamationCompany Updatemedium impact
Cruxal's analysis: Aster DM Quality Care Limited has received formal trading approval from the NSE and BSE…
Read the full analysis - Transcript of earning conference call held for the quarter ended 30 June 2026Company Updatehigh impact
Cruxal's analysis: Aster DM Quality Care Limited reported strong Q1 FY27 proforma results, with revenue from…
Read the full analysis - Newspaper publication regarding unaudited financial results for the quarter ended 30 June 2026Company Updatelow impact
Cruxal's analysis: Aster DM Quality Care Limited has published its unaudited standalone and consolidated…
Read the full analysis - Approval of Notice of 18th AGM and Postal Ballot and other required disclosuresCompany Updatemedium impact
Cruxal's analysis: Aster DM Quality Care Limited has announced the termination of its operations and…
Read the full analysis - Press release in relation to unaudited financial results for the quarter ended 30 June 2026Company Updatehigh impact
Cruxal's analysis: Aster DM Quality Care Limited (formerly Aster DM Healthcare) has reported robust combined…
Read the full analysis - Investor presentation for earnings conference call with analysts/ institutional investors scheduled for 5 August 2026Company Updatehigh impact
Cruxal's analysis: Aster DM Quality Care Limited (formerly Aster DM Healthcare) has released its Q1 FY27…
Read the full analysis - Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30 June 2026Resultmedium impact
Cruxal's analysis: Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited) reported…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Aster DM Healthcare Ltd
Cruxal reads every Aster DM Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.